Global Monoclonal Antibodies Market Insights, Forecast to 2028

Publisher Name :
Date: 16-Mar-2022
No. of pages: 94
Inquire Before Buying

Monoclonal Antibodies market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Erythropoietin (EPO)

- Human Growth Hormone (HGH)

- Granulocyte- Colony Stimulating Factor (G-CSF)

- Monoclonal Antibody (mAb)

- Insulin

- Interferon (IFN)

- Others

Segment by Application

- Anti-Cancer

- Anti-Inflammatory/Autoimmune

By Company

- Biocon

- Celltrion

- Dr. Reddy's Laboratories

- Hospira

- 3SBio

- Accord Healthcare

- AET Biotech

- Allergan

- Amega Biotech

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Monoclonal Antibodies Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Monoclonal Antibodies Product Introduction
1.2 Market by Type
1.2.1 Global Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Market by Application
1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Monoclonal Antibodies Sales Estimates and Forecasts 2017-2028
2.2 Global Monoclonal Antibodies Revenue Estimates and Forecasts 2017-2028
2.3 Global Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Monoclonal Antibodies Sales by Region
2.4.1 Global Monoclonal Antibodies Sales by Region (2017-2022)
2.4.2 Global Sales Monoclonal Antibodies by Region (2023-2028)
2.5 Global Monoclonal Antibodies Revenue by Region
2.5.1 Global Monoclonal Antibodies Revenue by Region (2017-2022)
2.5.2 Global Monoclonal Antibodies Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Monoclonal Antibodies Sales by Manufacturers
3.1.1 Global Top Monoclonal Antibodies Manufacturers by Sales (2017-2022)
3.1.2 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Monoclonal Antibodies in 2021
3.2 Global Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
3.2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Revenue in 2021
3.3 Global Monoclonal Antibodies Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Monoclonal Antibodies Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Monoclonal Antibodies Sales by Type
4.1.1 Global Monoclonal Antibodies Historical Sales by Type (2017-2022)
4.1.2 Global Monoclonal Antibodies Forecasted Sales by Type (2023-2028)
4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
4.2 Global Monoclonal Antibodies Revenue by Type
4.2.1 Global Monoclonal Antibodies Historical Revenue by Type (2017-2022)
4.2.2 Global Monoclonal Antibodies Forecasted Revenue by Type (2023-2028)
4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
4.3 Global Monoclonal Antibodies Price by Type
4.3.1 Global Monoclonal Antibodies Price by Type (2017-2022)
4.3.2 Global Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Monoclonal Antibodies Sales by Application
5.1.1 Global Monoclonal Antibodies Historical Sales by Application (2017-2022)
5.1.2 Global Monoclonal Antibodies Forecasted Sales by Application (2023-2028)
5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
5.2 Global Monoclonal Antibodies Revenue by Application
5.2.1 Global Monoclonal Antibodies Historical Revenue by Application (2017-2022)
5.2.2 Global Monoclonal Antibodies Forecasted Revenue by Application (2023-2028)
5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
5.3 Global Monoclonal Antibodies Price by Application
5.3.1 Global Monoclonal Antibodies Price by Application (2017-2022)
5.3.2 Global Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
6.1 North America Monoclonal Antibodies Market Size by Type
6.1.1 North America Monoclonal Antibodies Sales by Type (2017-2028)
6.1.2 North America Monoclonal Antibodies Revenue by Type (2017-2028)
6.2 North America Monoclonal Antibodies Market Size by Application
6.2.1 North America Monoclonal Antibodies Sales by Application (2017-2028)
6.2.2 North America Monoclonal Antibodies Revenue by Application (2017-2028)
6.3 North America Monoclonal Antibodies Market Size by Country
6.3.1 North America Monoclonal Antibodies Sales by Country (2017-2028)
6.3.2 North America Monoclonal Antibodies Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Monoclonal Antibodies Market Size by Type
7.1.1 Europe Monoclonal Antibodies Sales by Type (2017-2028)
7.1.2 Europe Monoclonal Antibodies Revenue by Type (2017-2028)
7.2 Europe Monoclonal Antibodies Market Size by Application
7.2.1 Europe Monoclonal Antibodies Sales by Application (2017-2028)
7.2.2 Europe Monoclonal Antibodies Revenue by Application (2017-2028)
7.3 Europe Monoclonal Antibodies Market Size by Country
7.3.1 Europe Monoclonal Antibodies Sales by Country (2017-2028)
7.3.2 Europe Monoclonal Antibodies Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Monoclonal Antibodies Market Size by Type
8.1.1 Asia Pacific Monoclonal Antibodies Sales by Type (2017-2028)
8.1.2 Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2028)
8.2 Asia Pacific Monoclonal Antibodies Market Size by Application
8.2.1 Asia Pacific Monoclonal Antibodies Sales by Application (2017-2028)
8.2.2 Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2028)
8.3 Asia Pacific Monoclonal Antibodies Market Size by Region
8.3.1 Asia Pacific Monoclonal Antibodies Sales by Region (2017-2028)
8.3.2 Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Monoclonal Antibodies Market Size by Type
9.1.1 Latin America Monoclonal Antibodies Sales by Type (2017-2028)
9.1.2 Latin America Monoclonal Antibodies Revenue by Type (2017-2028)
9.2 Latin America Monoclonal Antibodies Market Size by Application
9.2.1 Latin America Monoclonal Antibodies Sales by Application (2017-2028)
9.2.2 Latin America Monoclonal Antibodies Revenue by Application (2017-2028)
9.3 Latin America Monoclonal Antibodies Market Size by Country
9.3.1 Latin America Monoclonal Antibodies Sales by Country (2017-2028)
9.3.2 Latin America Monoclonal Antibodies Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Monoclonal Antibodies Market Size by Type
10.1.1 Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2028)
10.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2028)
10.2 Middle East and Africa Monoclonal Antibodies Market Size by Application
10.2.1 Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2028)
10.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2028)
10.3 Middle East and Africa Monoclonal Antibodies Market Size by Country
10.3.1 Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2028)
10.3.2 Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Biocon
11.1.1 Biocon Corporation Information
11.1.2 Biocon Overview
11.1.3 Biocon Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Biocon Recent Developments
11.2 Celltrion
11.2.1 Celltrion Corporation Information
11.2.2 Celltrion Overview
11.2.3 Celltrion Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Celltrion Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Corporation Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dr. Reddy's Laboratories Recent Developments
11.4 Hospira
11.4.1 Hospira Corporation Information
11.4.2 Hospira Overview
11.4.3 Hospira Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hospira Recent Developments
11.5 3SBio
11.5.1 3SBio Corporation Information
11.5.2 3SBio Overview
11.5.3 3SBio Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 3SBio Recent Developments
11.6 Accord Healthcare
11.6.1 Accord Healthcare Corporation Information
11.6.2 Accord Healthcare Overview
11.6.3 Accord Healthcare Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Accord Healthcare Recent Developments
11.7 AET Biotech
11.7.1 AET Biotech Corporation Information
11.7.2 AET Biotech Overview
11.7.3 AET Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AET Biotech Recent Developments
11.8 Allergan
11.8.1 Allergan Corporation Information
11.8.2 Allergan Overview
11.8.3 Allergan Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Allergan Recent Developments
11.9 Amega Biotech
11.9.1 Amega Biotech Corporation Information
11.9.2 Amega Biotech Overview
11.9.3 Amega Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amega Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Monoclonal Antibodies Industry Chain Analysis
12.2 Monoclonal Antibodies Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Monoclonal Antibodies Production Mode & Process
12.4 Monoclonal Antibodies Sales and Marketing
12.4.1 Monoclonal Antibodies Sales Channels
12.4.2 Monoclonal Antibodies Distributors
12.5 Monoclonal Antibodies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Monoclonal Antibodies Industry Trends
13.2 Monoclonal Antibodies Market Drivers
13.3 Monoclonal Antibodies Market Challenges
13.4 Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Monoclonal Antibodies Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Erythropoietin (EPO)
Table 3. Major Manufacturers of Human Growth Hormone (HGH)
Table 4. Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
Table 5. Major Manufacturers of Monoclonal Antibody (mAb)
Table 6. Major Manufacturers of Insulin
Table 7. Major Manufacturers of Interferon (IFN)
Table 8. Major Manufacturers of Others
Table 9. Global Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 12. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Table 13. Global Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 14. Global Monoclonal Antibodies Sales Market Share by Region (2023-2028)
Table 15. Global Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
Table 17. Global Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Monoclonal Antibodies Revenue Market Share by Region (2023-2028)
Table 19. Global Monoclonal Antibodies Sales by Manufacturers (2017-2022) & (Kg)
Table 20. Global Monoclonal Antibodies Sales Share by Manufacturers (2017-2022)
Table 21. Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Global Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
Table 23. Monoclonal Antibodies Price by Manufacturers (2017-2022) &(USD/Kg)
Table 24. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2021)
Table 26. Monoclonal Antibodies Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Monoclonal Antibodies Product Offered
Table 28. Date of Manufacturers Enter into Monoclonal Antibodies Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 31. Global Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 32. Global Monoclonal Antibodies Sales Share by Type (2017-2022)
Table 33. Global Monoclonal Antibodies Sales Share by Type (2023-2028)
Table 34. Global Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 35. Global Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 36. Global Monoclonal Antibodies Revenue Share by Type (2017-2022)
Table 37. Global Monoclonal Antibodies Revenue Share by Type (2023-2028)
Table 38. Monoclonal Antibodies Price by Type (2017-2022) & (USD/Kg)
Table 39. Global Monoclonal Antibodies Price Forecast by Type (2023-2028) & (USD/Kg)
Table 40. Global Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 41. Global Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 42. Global Monoclonal Antibodies Sales Share by Application (2017-2022)
Table 43. Global Monoclonal Antibodies Sales Share by Application (2023-2028)
Table 44. Global Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 45. Global Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 46. Global Monoclonal Antibodies Revenue Share by Application (2017-2022)
Table 47. Global Monoclonal Antibodies Revenue Share by Application (2023-2028)
Table 48. Monoclonal Antibodies Price by Application (2017-2022) & (USD/Kg)
Table 49. Global Monoclonal Antibodies Price Forecast by Application (2023-2028) & (USD/Kg)
Table 50. North America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 51. North America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 52. North America Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 53. North America Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 54. North America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 55. North America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 56. North America Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 57. North America Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 58. North America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 59. North America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 60. North America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 61. North America Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 62. Europe Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 63. Europe Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 64. Europe Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 65. Europe Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 66. Europe Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 67. Europe Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 68. Europe Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 69. Europe Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 70. Europe Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 71. Europe Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 72. Europe Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 73. Europe Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 74. Asia Pacific Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 75. Asia Pacific Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 76. Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 77. Asia Pacific Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 78. Asia Pacific Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 79. Asia Pacific Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 80. Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 81. Asia Pacific Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 82. Asia Pacific Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
Table 83. Asia Pacific Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
Table 84. Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
Table 85. Asia Pacific Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
Table 86. Latin America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 87. Latin America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 88. Latin America Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 89. Latin America Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 90. Latin America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 91. Latin America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 92. Latin America Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 93. Latin America Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 94. Latin America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 95. Latin America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 96. Latin America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 97. Latin America Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
Table 99. Middle East and Africa Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
Table 100. Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
Table 103. Middle East and Africa Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
Table 104. Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
Table 106. Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
Table 107. Middle East and Africa Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
Table 108. Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
Table 109. Middle East and Africa Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
Table 110. Biocon Corporation Information
Table 111. Biocon Description and Major Businesses
Table 112. Biocon Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 113. Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Biocon Recent Developments
Table 115. Celltrion Corporation Information
Table 116. Celltrion Description and Major Businesses
Table 117. Celltrion Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 118. Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Celltrion Recent Developments
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Major Businesses
Table 122. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 123. Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Dr. Reddy's Laboratories Recent Developments
Table 125. Hospira Corporation Information
Table 126. Hospira Description and Major Businesses
Table 127. Hospira Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 128. Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Hospira Recent Developments
Table 130. 3SBio Corporation Information
Table 131. 3SBio Description and Major Businesses
Table 132. 3SBio Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 133. 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. 3SBio Recent Developments
Table 135. Accord Healthcare Corporation Information
Table 136. Accord Healthcare Description and Major Businesses
Table 137. Accord Healthcare Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 138. Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Accord Healthcare Recent Developments
Table 140. AET Biotech Corporation Information
Table 141. AET Biotech Description and Major Businesses
Table 142. AET Biotech Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 143. AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AET Biotech Recent Developments
Table 145. Allergan Corporation Information
Table 146. Allergan Description and Major Businesses
Table 147. Allergan Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 148. Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Allergan Recent Developments
Table 150. Amega Biotech Corporation Information
Table 151. Amega Biotech Description and Major Businesses
Table 152. Amega Biotech Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 153. Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Amega Biotech Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Monoclonal Antibodies Distributors List
Table 158. Monoclonal Antibodies Customers List
Table 159. Monoclonal Antibodies Market Trends
Table 160. Monoclonal Antibodies Market Drivers
Table 161. Monoclonal Antibodies Market Challenges
Table 162. Monoclonal Antibodies Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Product Picture
Figure 3. Global Monoclonal Antibodies Market Share by Type in 2021 & 2028
Figure 3. Erythropoietin (EPO) Product Picture
Figure 4. Human Growth Hormone (HGH) Product Picture
Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Figure 6. Monoclonal Antibody (mAb) Product Picture
Figure 7. Insulin Product Picture
Figure 8. Interferon (IFN) Product Picture
Figure 9. Others Product Picture
Figure 10. Global Monoclonal Antibodies Market Share by Application in 2021 & 2028
Figure 11. Anti-Cancer
Figure 12. Anti-Inflammatory/Autoimmune
Figure 13. Monoclonal Antibodies Report Years Considered
Figure 14. Global Monoclonal Antibodies Sales 2017-2028 (Kg)
Figure 15. Global Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Monoclonal Antibodies Revenue 2017-2028 (US$ Million)
Figure 17. Global Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
Figure 19. Global Monoclonal Antibodies Sales Market Share by Region (2023-2028)
Figure 20. North America Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
Figure 21. North America Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
Figure 23. Europe Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
Figure 25. Asia-Pacific Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
Figure 27. Latin America Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
Figure 29. Middle East & Africa Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Monoclonal Antibodies Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Monoclonal Antibodies in the World: Market Share by Monoclonal Antibodies Revenue in 2021
Figure 32. Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 34. Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 35. Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 36. Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 37. North America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 38. North America Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 39. North America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 40. North America Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 41. North America Monoclonal Antibodies Sales Share by Country (2017-2028)
Figure 42. North America Monoclonal Antibodies Revenue Share by Country (2017-2028)
Figure 43. U.S. Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 46. Europe Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 47. Europe Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 48. Europe Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 49. Europe Monoclonal Antibodies Sales Share by Country (2017-2028)
Figure 50. Europe Monoclonal Antibodies Revenue Share by Country (2017-2028)
Figure 51. Germany Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 52. France Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Monoclonal Antibodies Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Monoclonal Antibodies Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Monoclonal Antibodies Revenue Share by Region (2017-2028)
Figure 62. China Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 65. India Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
Figure 73. Latin America Monoclonal Antibodies Revenue Market Share by Ty
  • Global Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Antibody Production Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 121
    Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
  • Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Antibody Production market: According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Antibody Production Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 117
    Report Overview: The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period. This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
  • Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
    Published: 30-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
  • Monoclonal Antibody Industry Forecasts - China Focus
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 92
    This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
  • Monoclonal Antibody Companies in China
    Published: 27-Nov-2023        Price: US 1800 Onwards        Pages: 73
    This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
  • Monoclonal Antibody Markets in China
    Published: 27-Nov-2023        Price: US 4000 Onwards        Pages: 219
    China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs